NCT06813742View on ClinicalTrials.gov

18F-mFBG PET Imaging in the Evaluation of Pheochromocytoma

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

May 1, 2023

Primary Completion Date

December 5, 2025

Study Completion Date

December 31, 2026

Conditions
Pheochromocytoma
Interventions
DRUG

18F-MFBG

Patients with pheochromocytoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.

Trial Locations (2)

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

310006

RECRUITING

The First Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER